-
公开(公告)号:US20110129448A1
公开(公告)日:2011-06-02
申请号:US13023381
申请日:2011-02-08
申请人: Gary J. BRIDGER , Michael J. Abrams , Geoffrey W. Henson , Ronald Trevor MacFarland , Gary B. Calandra , Hal E. Broxmeyer , David C. Dale
发明人: Gary J. BRIDGER , Michael J. Abrams , Geoffrey W. Henson , Ronald Trevor MacFarland , Gary B. Calandra , Hal E. Broxmeyer , David C. Dale
CPC分类号: A61K31/395 , A61K31/33 , A61K31/4427 , A61K31/496 , A61K31/55 , A61K31/551 , A61K31/555 , A61K35/28 , A61K38/193 , A61K38/195 , A61K2035/124 , C12N5/0647 , A61K2300/00
摘要: Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the formula Z-linker-Z′ (1) or pharmaceutically acceptable salt thereof wherein Z is a cyclic polyamine containing 9-32 ring members of which 3-8 are nitrogen atoms, said nitrogen atoms separated from each other by at least 2 carbon atoms, and wherein said heterocycle may optionally contain additional heteroatoms besides nitrogen and/or may be fused to an additional ring system; or Z is of the formula wherein A comprises a monocyclic or bicyclic fused ring system containing at least one N and B is H or an organic moiety of 1-20 atoms, Z′ may be embodied in a form as defined by Z above, or alternatively may be of the formula —N(R)—(CR2)n—X wherein each R is independently H or straight, branched or cyclic alkyl (1-6C), n is 1 or 2, and X is an aromatic ring, including heteroaromatic rings, or is a mercaptan; “linker” represents a bond, alkylene (1-6C) or may comprise aryl, fused aryl, oxygen atoms contained in an alkylene chain, or may contain keto groups or nitrogen or sulfur atoms.
摘要翻译: 公开了使用结合趋化因子受体CXCR4的化合物来提高动物受试者祖细胞和干细胞计数的方法。 这种化合物的优选实施方案是式Z-接头-Z'(1)或其药学上可接受的盐,其中Z是含有9-32个环成员的环状多胺,其中3-8个是氮原子,所述氮原子从每个 另外通过至少2个碳原子,并且其中所述杂环可以任选地含有除氮之外的另外的杂原子和/或可以与另外的环系稠合; 或Z具有下式:其中A包含含有至少一个N的单环或双环稠合环体系,B是H或1-20个原子的有机部分,Z'可以以上述Z所定义的形式实施,或 或者可以是式-N(R) - (CR 2)n -X,其中每个R独立地为H或直链,支链或环状烷基(1-6C),n为1或2,X为芳环, 包括杂芳环,或是硫醇; “接头”表示键,亚烷基(1-6C)或可包含亚烷基链中所含的芳基,稠合芳基,氧原子,或可含有酮基或氮或硫原子。
-
公开(公告)号:US20100105915A1
公开(公告)日:2010-04-29
申请号:US12612488
申请日:2009-11-04
申请人: Gary J. BRIDGER , Renato Skerlj , Ai Kaller , Curtis Harwig , David Bogucki , Trevor R. Wilson , Jason Crawford , Ernest J. Mceachern , Bem Atsma , Siqiao Nan , Yuanxi Zhou , Dominique Schols
发明人: Gary J. BRIDGER , Renato Skerlj , Ai Kaller , Curtis Harwig , David Bogucki , Trevor R. Wilson , Jason Crawford , Ernest J. Mceachern , Bem Atsma , Siqiao Nan , Yuanxi Zhou , Dominique Schols
IPC分类号: C07D401/02
CPC分类号: C07D239/42 , A61K45/06 , C07D213/38 , C07D215/40 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D451/04 , C07D471/04 , C07D487/04
摘要: Heterocyclic compounds that bind chemokine receptors and inhibit the binding of their natural ligands are disclosed. The invention compounds are protective against infection by HIV and exert effects characteristic of antagonists to the CXCR4 receptor.
摘要翻译: 公开了结合趋化因子受体并抑制其天然配体结合的杂环化合物。 本发明化合物可防止HIV感染并发挥拮抗剂对CXCR4受体特征的作用。
-
3.
公开(公告)号:US07135570B2
公开(公告)日:2006-11-14
申请号:US10959823
申请日:2004-10-06
IPC分类号: C07D215/00
CPC分类号: C07D217/22 , C07D215/06 , C07D215/20 , C07D215/38 , C07D215/40 , C07D215/42 , C07D215/48 , C07D221/04 , C07D241/42 , C07D307/79 , C07D491/04
摘要: This invention describes various processes for synthesis and resolution of racemic amino-substituted fused bicyclic ring systems. One process utilizes selective hydrogenation of an amino-substituted fused bicyclic aromatic ring system. An alternative process prepares the racemic amino-substituted fused bicyclic ring system via nitrosation. In addition, the present invention describes the enzymatic resolution of a racemic mixture to produce the (R)— and (S)— forms of amino-substituted fused bicyclic rings as well as a racemization process to recycle the unpreferred enantioner. Further provided by this invention is an asymmetric synthesis of the (R)— or (S)— enantiomer of primary amino-substituted fused bicyclic ring systems.
摘要翻译: 本发明描述了合成和拆分外消旋氨基取代的稠合双环体系的各种方法。 一个方法利用氨基取代的稠合双环芳族环系统的选择性氢化。 另一种方法是通过亚硝化制备外消旋氨基取代的稠合双环体系。 此外,本发明描述了外消旋混合物的酶拆分以产生(R) - 和(S) - 形式的氨基取代的稠合双环,以及外消旋化方法以回收未预期的对映异构体。 本发明进一步提供的是伯氨基取代的稠合双环体系的(R) - 或(S) - 对映异构体的不对称合成。
-
公开(公告)号:US5591748A
公开(公告)日:1997-01-07
申请号:US277456
申请日:1994-07-19
IPC分类号: C07D209/54 , C07D401/04 , C07D403/04 , C07D451/04 , C07D453/02 , A61K31/44 , C07D453/00
CPC分类号: C07D451/04 , C07D209/54 , C07D401/04 , C07D403/04 , C07D453/02
摘要: Invented are substituted azaspirane compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to induce an immunosuppressive effect in a mammal in need thereof.
摘要翻译: 发明的是取代的氮杂环丙烷化合物,含有这些化合物的药物组合物,以及使用这些化合物在有需要的哺乳动物中诱导免疫抑制作用的方法。
-
公开(公告)号:US20100178271A1
公开(公告)日:2010-07-15
申请号:US12376591
申请日:2007-08-07
申请人: Gary J. Bridger , Louis M. Pelus
发明人: Gary J. Bridger , Louis M. Pelus
CPC分类号: A61K38/195 , A61K31/395 , A61K38/193 , A61K2300/00
摘要: Methods to mobilize progenitor and/or stem cells from the bone marrow to the bloodstream by administering a combination of at least one CXCR4 inhibitor, at least one CXCR2 agonist, and G-CSF are described. The combinations may also be used to increase the effectiveness of chemotherapy and radiation therapies for hematopoietic malignancies.
摘要翻译: 描述了通过施用至少一种CXCR4抑制剂,至少一种CXCR2激动剂和G-CSF的组合将祖细胞和/或干细胞从骨髓移动到血流的方法。 这些组合也可用于增加造血恶性肿瘤的化疗和放射治疗的有效性。
-
公开(公告)号:US20080287454A1
公开(公告)日:2008-11-20
申请号:US12182044
申请日:2008-07-29
申请人: Gary J. BRIDGER , Eva Maria BOEHRINGER , Zhongren WANG , Dominique SCHOLS , Renato Tony SKERLJ , David Earl BOGUCKI
发明人: Gary J. BRIDGER , Eva Maria BOEHRINGER , Zhongren WANG , Dominique SCHOLS , Renato Tony SKERLJ , David Earl BOGUCKI
IPC分类号: A61K31/395 , A61K31/4427 , A61K31/4353 , A61K31/52 , A61P35/00 , A61P25/00 , A61P19/02 , A61K31/496 , A61K31/497
CPC分类号: C07D473/00 , C04B35/632 , C07D257/02 , C07D401/06 , C07D401/12 , C07D403/12 , C07D409/12 , C07D471/06
摘要: The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV- or FIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.
摘要翻译: 本发明涉及新的抗病毒化合物,药物组合物及其应用。 更具体地,本发明涉及在针对HIV或FIV感染的细胞的标准测试中具有活性的单环多胺的衍生物以及与介导多种哺乳动物胚胎发育过程的配体与趋化因子受体的结合相关的其它生物活性。
-
7.
公开(公告)号:US07452994B2
公开(公告)日:2008-11-18
申请号:US11598955
申请日:2006-11-14
IPC分类号: C07D215/00 , C07D217/00
CPC分类号: C07D217/22 , C07D215/06 , C07D215/20 , C07D215/38 , C07D215/40 , C07D215/42 , C07D215/48 , C07D221/04 , C07D241/42 , C07D307/79 , C07D491/04
摘要: This invention describes various processes for synthesis and resolution of racemic amino-substituted fused bicyclic ring systems. One process utilizes selective hydrogenation of an amino-substituted fused bicyclic aromatic ring system. An alternative process prepares the racemic amino-substituted fused bicyclic ring system via nitrosation. In addition, the present invention describes the enzymatic resolution of a racemic mixture to produce the (R)- and (S)-forms of amino-substituted fused bicyclic rings as well as a racemization process to recycle the unpreferred enantioner. Further provided by this invention is an asymmetric synthesis of the (R)- or (S)-enantiomer of primary amino-substituted fused bicyclic ring systems.
摘要翻译: 本发明描述了合成和拆分外消旋氨基取代的稠合双环体系的各种方法。 一个方法利用氨基取代的稠合双环芳族环系统的选择性氢化。 另一种方法是通过亚硝化制备外消旋氨基取代的稠合双环体系。 此外,本发明描述了外消旋混合物的酶拆分以产生氨基取代的稠合双环的(R) - 和(S)形式,以及外消旋化方法以回收未预期的对映异构体。 本发明进一步提供的是主要氨基取代的稠合双环体系的(R) - 或(S) - 对映体的不对称合成。
-
公开(公告)号:US07354934B2
公开(公告)日:2008-04-08
申请号:US11301725
申请日:2005-12-13
申请人: Gary J. Bridger , Al Kaller , Curtis Harwig , Renato T. Skerlj , David Bogucki , Trevor R. Wilson , Jason B. Crawford , Ernest J. McEachern , Bem Atsma , Siqiao Nan , Yuanxi Zhou , Dominique Schols , Christopher Dennis Smith , Maria R. Di Fluri
发明人: Gary J. Bridger , Al Kaller , Curtis Harwig , Renato T. Skerlj , David Bogucki , Trevor R. Wilson , Jason B. Crawford , Ernest J. McEachern , Bem Atsma , Siqiao Nan , Yuanxi Zhou , Dominique Schols , Christopher Dennis Smith , Maria R. Di Fluri
IPC分类号: A61K31/4709 , C07D403/12
CPC分类号: C07D401/14 , C07D235/14 , C07D401/12 , C07D403/12 , C07D471/04 , C07D471/06 , C07D491/04
摘要: The invention relates to heterocyclic compounds consisting of a core nitrogen atom surrounded by three pendant groups, wherein two of the three pendant groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third pendant group contains N and optionally contains additional rings. The compounds bind to chemokine receptors, including CXCR4 and CCR5, and demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
-
公开(公告)号:US07291631B2
公开(公告)日:2007-11-06
申请号:US10823494
申请日:2004-04-12
申请人: Gary J. Bridger , Ernest J. McEachern , Renato Skerlj , Dominique Schols , Ian Baird , Al Kaller , Curtis Harwig , Yongbao Zhu , Gang Chen , Krystyna Skupinska
发明人: Gary J. Bridger , Ernest J. McEachern , Renato Skerlj , Dominique Schols , Ian Baird , Al Kaller , Curtis Harwig , Yongbao Zhu , Gang Chen , Krystyna Skupinska
IPC分类号: C07D401/02 , A61K31/4439
CPC分类号: C07D413/14 , C07D213/38 , C07D213/61 , C07D213/65 , C07D213/69 , C07D213/70 , C07D213/73 , C07D213/74 , C07D213/75 , C07D213/76 , C07D213/80 , C07D213/82 , C07D213/89 , C07D401/12 , C07D401/14 , C07D409/14 , C07D417/12 , C07D417/14 , C07D451/04 , C07D471/06
摘要: The present invention relates to compounds that bind to chemokine receptors, and having the formula wherein each A, X, Y, R1, R2 and R3 are substituents. The present invention also relates to methods of using such compounds, such as in treating HIV infection and inflammatory conditions such as rheumatoid arthritis. Furthermore, the present invention relates to methods to elevate progenitor and stem cell counts, as well as methods to elevate white blood cell counts, using such compounds.
摘要翻译: 本发明涉及结合趋化因子受体的化合物,具有下式:其中每个A,X,Y,R 1,R 2和R 3, / SUP>是取代基。 本发明还涉及使用这些化合物的方法,例如用于治疗HIV感染和炎性病症如类风湿性关节炎。 此外,本发明涉及使用这些化合物提高祖细胞和干细胞计数的方法以及升高白细胞计数的方法。
-
公开(公告)号:US5817807A
公开(公告)日:1998-10-06
申请号:US659500
申请日:1996-06-06
申请人: Gary J. Bridger , Sreenivasan Padmanabhan , Renato T. Skerlj , Pedro E. Hernandez-Abad , Milind P. Sant
发明人: Gary J. Bridger , Sreenivasan Padmanabhan , Renato T. Skerlj , Pedro E. Hernandez-Abad , Milind P. Sant
IPC分类号: C07D487/08 , A61K31/395 , A61K31/415 , A61K31/44 , A61K31/4427 , A61K31/4433 , A61K31/495 , A61K31/505 , A61P31/12 , C07D255/02 , C07D257/02 , C07D259/00 , C07D401/12 , C07D403/12 , C07D409/12 , A61K31/33 , C07D257/00
CPC分类号: C07D401/12 , C07D255/02 , C07D257/02 , C07D259/00 , C07D403/12 , C07D409/12
摘要: Macrocyclic compounds having 1, 4, 8, 11-tetraazacyclotetradecanyl group, show good selectivity against HIV-1 and HIV-2, in in vitro tests are disclosed.
摘要翻译: 在体外试验中公开了具有1,4,8,11-四氮杂环十四烷基的大环化合物对HIV-1和HIV-2具有良好的选择性。
-
-
-
-
-
-
-
-
-